View TB-500 Certificate of Analysis Why Choose This Stack? BPC-157 and TB-500 are often studied together for their complementary mechanisms in tissue repair research. Understanding their distinct backgrounds and how they work provides important context for researchers. The History & Origins BPC-157 (Body Protection Compound-157) is a synthetic peptide originally derived from a protective protein found in gastric juice . First characterized in the 1990s, this 15-amino-acid sequence was isolated from gastric mucosal extracts and has demonstrated remarkable stability across different biological environments . TB-500 is a synthetic analogue of thymosin beta-4, a naturally occurring 43-amino-acid polypeptide found in virtually all human and animal cells . This peptide is highly conserved across species and plays fundamental roles in cellular differentiation, tissue remodeling, and wound healing processes . How They Work: Distinct But Complementary While both peptides are involved in tissue repair research, they operate through different biological pathways : BPC-157 Research Mechanisms Modulates angiogenesis through upregulation of vascular endothelial growth factor (VEGF) expression Influences nitric oxide synthase activity, affecting vascular tone and tissue perfusion Interacts with growth hormone receptor signaling pathways Exhibits anti-inflammatory properties through modulation of pro-inflammatory cytokine production Enhances collagen synthesis and extracellular matrix remodeling TB-500 Research Mechanisms Regulates actin dynamics — binding to G-actin to facilitate cellular migration essential for wound healing Demonstrates potent angiogenic properties through endothelial cell migration and proliferation Modulates inflammatory responses and promotes resolution pathways Shifts macrophage polarization toward anti-inflammatory phenotypes Exhibits cardioprotective and neuroprotective properties in preclinical studies The Synergistic Potential Researchers often study these peptides together because their mechanisms are complementary rather than duplicative : BPC-157 is frequently examined in localized tissue environments — tendon and ligament structures, gastrointestinal tissue, and muscle-tendon junctions . Its effects appear more targeted toward signaling environment modulation. TB-500 is associated with systemic effects — influencing cytoskeletal behavior, cell migration dynamics, and structural remodeling across multiple tissues . Together, they represent a multi-pathway approach to tissue repair research: BPC-157 focusing on vascular signaling and localized repair, while TB-500 addresses cellular movement and structural organization Product A: BPC-157 Catalogue Number: 001223 CAS Number: 137525-51-0 Molecular Formula: C₆₂H₉₈N₁₆O₂₂ Molecular Weight: 1419.6 g/mol Purity: ≥98% (HPLC) Form: Lyophilised powder Quantity: 10mg per vial Laboratory research compound evaluated in controlled preclinical settings. Intended strictly for laboratory and educational research applications. For research use only. Restricted to in vitro laboratory experimentation and cannot be used in clinical or investigational studies, applied in any medical or therapeutic context, or distributed for purposes outside regulated laboratory research. Product B: TB-500 (Thymosin Beta-4) Catalogue Number: 00213 CAS Number: 77591-33-4 Molecular Formula: C₃₈H₆₈N₁₀O₁₄ Molecular Weight: 889.0 g/mol Purity: ≥98% (HPLC) Form: Lyophilised powder Quantity: 10mg per vial Laboratory research compound evaluated in controlled preclinical settings. Intended strictly for laboratory and educational research applications. For research use only. Restricted to in vitro laboratory experimentation and cannot be used in clinical or investigational studies, applied in any medical or therapeutic context, or distributed for purposes outside regulated laboratory research.
Related products
